Cite
HARVARD Citation
Jeremic, B. et al. (2018). Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC– Ain't no mountain high enough…. to keep me getting to you. Lung cancer. pp. 172-173. [Online].